Jose A. Esteves

Jose A. Esteves

Partner, Intellectual Property and Technology

Jose A. Esteves focuses on assisting clients in maximizing their intellectual property, technology and data assets. He combines over 25 years in legal practice with a master’s degree in engineering and three years as a computer design engineer, and provides clients with a unique combination of deep and broad experience in each of high-tech, software/IT, fintech, biopharma/health care, digital health and e-commerce/consumer products.

Bio

Mr. Esteves splits time between Skadden’s New York and Palo Alto offices, providing clients with the benefit of perspectives from both markets.

In connection with his practice, he frequently structures, negotiates and advises on strategic transactions, such as collaborations, joint ventures, cloud/outsourcing arrangements and other complex transactions; development, licensing, supply, distribution, marketing and support arrangements; and IP-backed monetization and financing transactions. He also regularly counsels clients on IP, technology, and data legal and commercial issues, as well as on privacy, cybersecurity and emerging issues in data rights, artificial intelligence, IoT, blockchain and other key technologies. In recognition of his work, Intellectual Asset Management magazine has repeatedly included Mr. Esteves on its list of the IAM Strategy 300 — The World’s Leading IP Strategists and the IAM Patent 1000, where he is described as “a top IP value creation expert.”

Representative transactions and clients include:

Financial/Fintech:

  • JPMC in connection with its divestiture of the Quorum blockchain platform to ConsenSys, the licensing and hosting of JPMC’s online banking platform and in certain other transactions;
  • BlackRock in connection with intellectual property, technology and data rights aspects of several strategic transactions;
  • Moody’s Analytics in its acquisition of financial data aggregation and analytics providers Reis, Inc. and Bureau Van Dijk, and in evaluating certain AI technology;
  • Visa, Inc. in its signed but terminated acquisition of financial data aggregator Plaid, Inc.;
  • Fortress Investment Group in numerous transactions, including various IP-backed investments and financings, and the joint ownership of a software lending platform;
  • Ripple in connection with certain contract arrangements for its payments network; and
  • Polypaths LLC in software and data licensing and collaboration arrangements for its fixed-income analytics platform.

High-Tech:

  • Intel in its acquisition of Mobileye (autonomous driving systems) and its divestiture of (i) Wind River (real-time OS developer), (ii) its 5G modem business to Apple Inc. and (iii) its “connected home” division and related licensing and supply agreements;
  • IMAX Corporation in strategic technology transactions, including an augmented reality/ virtual reality collaboration with Google; in licensing, development and supply arrangements for next-generation movie cameras and projectors; and its global reorganization;
  • Merck in the sale and ancillary agreements relating its crop biosciences business;
  • Nilfisk in its collaboration with Brain, Inc. to develop AI technology for autonomous industrial vehicles;
  • MIPS Technologies, Inc. in its patent sale to a consortium and simultaneous sale of its operating business — ranked as a top matter by the Financial Times’ Innovative Lawyers report;
  • Nokia Corporation in its merger with Alcatel Lucent, renegotiation of a technology joint venture and a product-line acquisition;
  • PMC-Sierra in connection with a strategic product-line acquisition and related development and supply agreements; a strategic license, development and supply agreement with a Big Tech company; and in the sale of its business; and
  • ExxonMobil in a technology research and design and licensing joint venture with Rosneft.

Biopharma:

  • Pfizer, Inc. in more than a dozen collaborations and M&A transactions; and in license, supply and commercial agreements;
  • Regeneron Pharmaceuticals, Inc. in several drug collaborations;
  • Exact Sciences, Otsuka Pharmaceutical Co., Ferrer S.A., Shionogi & Co., Ltd., Amylin Pharmaceuticals, Inc., PDI, Inc., Chiasma, Inc. and Novo Nordisk, among others, in various collaboration, M&A and licensing arrangements; and
  • Goldman Sachs, Fortress-Drawbridge, Theravance, Valeant Pharmaceuticals, Pfizer, Ferrer S.A. and others in various biopharma royalty interest purchases and securitizations, project financings, and IP- and royalty-collateralized financings.

Health Care/Digital Health:

  • a major health insurer in more than one dozen transactions, including acquisitions and divestitures of other health insurers, health care providers and health care IT companies; and several digital health transactions, including an investment, with option to control, in a PBM disruptor; a joint venture with a unicorn startup to transform financial management for health care payors; and in analyzing AI, medical/health data, telemedicine and app-based consumer health care targets;
  • Pfizer, Inc. in its collaboration with Google/Verily with respect to digitally innovative patient-centered clinical trials;
  • Dassault Systemes in its acquisition of Medidata Solutions, Inc. (including deep-dive analysis of data rights, privacy and cybersecurity, and deployment of AI); and
  • a European outsourcer of medical radiological services in connection with the development, licensing and hosting of a next-generation platform for operating hospital radiology units.

Cloud/Outsourcing/SaaS:

  • PT Emtek in its Google Cloud arrangement for PT Emtek’s messaging and e-commerce platform with 85 million users;
  • PHH Corporation in various mortgage origination and servicing outsourcing agreements;
  • a blockchain platform provider in connection with a cloud hosting and commercialization joint venture with a major cloud provider;
  • a deep-dive analysis of a $1 billion-plus IoT platform hosting arrangement with a major cloud provider; and
  • United Airlines, US Airways, Aerolineas Argentina and Kingfisher Airways in airline hosting and computer reservation system agreements with SABRE and Galileo, as applicable.

Media/Content/Consumer Products:

  • Yankees Entertainment Sports Network (YES Network) in its licensing of media rights to New York Yankees baseball games;
  • Keurig in a joint venture to develop an innovative consumer appliance; and
  • D.E. Master Blenders in a joint venture with Mondelez International to form world’s largest “pure play” coffee company, including various ancillary technology and product development, licensing and supply arrangements.

Recent Speaking Engagements

  • Panelist, CIO Leadership Forums on AI and Emerging State Data Privacy Laws, 2020-21
  • Presenter, “Internet of Medical Things,” Practising Law Institute Internet of Things conference, 2019-present
  • Chairperson, “IP Monetization: Maximizing the Value of Your IP Assets” conference, Practising Law Institute, 2009-20
  • Moderator, Panel on AI, Big Data and Blockchain, IP Dealmakers Forum, 2016-19
  • Moderator, Panel on Investing in Invention, IP Investment Conference

Engineering Experience

Prior to attending law school, Mr. Esteves earned an M.S. in electrical engineering and was a computer design engineer at IBM for three years.

Credentials

Education

  • J.D., Yale Law School, 1995
  • M.S. (Electrical Engineering), Columbia University, 1992
  • B.S. (Electrical Engineering), New Jersey Institute of Technology, 1989 (magna cum laude)

Admissions

  • California
  • New York

Jose A. Esteves

Partner, Intellectual Property and Technology
jose.esteves@skadden.com